Bright Minds Biosciences (DRUG) News Today $51.11 -2.17 (-4.07%) Closing price 04:00 PM EasternExtended Trading$51.50 +0.39 (+0.76%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRUG Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Bright Minds Biosciences (NASDAQ:DRUG) Upgraded to Hold at Wall Street ZenSeptember 21 at 3:11 AM | americanbankingnews.comBright Minds Biosciences (NASDAQ:DRUG) Upgraded by Wall Street Zen to Hold RatingSeptember 20 at 2:09 AM | marketbeat.comHC Wainwright Reaffirms Buy Rating for Bright Minds Biosciences (NASDAQ:DRUG)September 17, 2025 | americanbankingnews.comBright Minds Biosciences (NASDAQ:DRUG) Given Buy Rating at HC WainwrightSeptember 16, 2025 | marketbeat.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Receives $81.00 Average Price Target from BrokeragesSeptember 14, 2025 | americanbankingnews.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Recommendation of "Buy" by AnalystsSeptember 11, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Now Covered by Analysts at BTIG ResearchSeptember 10, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Acquires 67,500 Shares of Bright Minds Biosciences Inc. $DRUGSeptember 9, 2025 | marketbeat.comBTIG Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy RecommendationSeptember 8, 2025 | msn.comLarge Patient Population Is Key Driver For Bright Minds' GrowthSeptember 8, 2025 | finance.yahoo.comBright Minds announces ATM offering up to $100 millionSeptember 5, 2025 | msn.comOMERS ADMINISTRATION Corp Makes New Investment in Bright Minds Biosciences Inc. $DRUGSeptember 5, 2025 | marketbeat.comBright Minds Biosciences Launches $100 Million At-The-Market OfferingSeptember 5, 2025 | msn.comBRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERINGSeptember 4, 2025 | finance.yahoo.comPsychedelic: Bright Minds reports preclinical BMB-201 resultsSeptember 4, 2025 | msn.comBright Minds says BMB-201 outperforms sumatriptan in preclinical modelSeptember 4, 2025 | msn.comBright Minds Biosciences Announces BMB‑201 Outperforms Sumatriptan in Validated Preclinical Vascular Headache ModelSeptember 4, 2025 | markets.businessinsider.comBright Minds Biosciences Inc. $DRUG Shares Sold by RA Capital Management L.P.September 4, 2025 | marketbeat.comBright Minds Biosciences Inc. (DRUG) Advances Phase 2 Trial for Drug-Resistant EpilepsySeptember 2, 2025 | finance.yahoo.comWalleye Capital LLC Sells 18,170 Shares of Bright Minds Biosciences Inc. $DRUGAugust 30, 2025 | marketbeat.comBright Minds Biosciences to Present at Upcoming ConferencesAugust 25, 2025 | markets.businessinsider.comCantor Fitzgerald Has Positive View of DRUG FY2025 EarningsAugust 23, 2025 | marketbeat.comHC Wainwright Has Positive Estimate for DRUG FY2025 EarningsAugust 23, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Given "Buy" Rating at HC WainwrightAugust 21, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Issues Earnings ResultsAugust 18, 2025 | marketbeat.comBright Minds Biosciences Reports Q3 2025 Financial ResultsAugust 15, 2025 | msn.comDRUG | Bright Minds Biosciences Inc. Stock Price & News - WSJAugust 10, 2025 | wsj.comBright Minds Biosciences (DRUG) Projected to Post Quarterly Earnings on WednesdayAugust 7, 2025 | marketbeat.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Buy" from AnalystsJuly 21, 2025 | marketbeat.comAnalysts Offer Predictions for DRUG FY2025 EarningsJuly 4, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Earns Overweight Rating from Cantor FitzgeraldJuly 2, 2025 | marketbeat.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Rating of "Buy" by AnalystsJune 26, 2025 | marketbeat.comDRUG FY2025 EPS Forecast Increased by Cantor FitzgeraldJune 11, 2025 | marketbeat.com40,379 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by Millennium Management LLCJune 4, 2025 | marketbeat.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of "Buy" from AnalystsJune 1, 2025 | marketbeat.comBright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare ConferenceMay 28, 2025 | finance.yahoo.comWhat is Chardan Capital's Forecast for DRUG FY2025 Earnings?May 27, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Outlook for DRUG EarningsMay 27, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Cut to "Sell" at Wall Street ZenMay 24, 2025 | marketbeat.comChardan Capital Reiterates Buy Rating for Bright Minds Biosciences (NASDAQ:DRUG)May 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Buys Shares of 135,189 Bright Minds Biosciences Inc. (NASDAQ:DRUG)May 22, 2025 | marketbeat.comBright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025May 20, 2025 | globenewswire.comJanus Henderson Group PLC Buys New Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)May 18, 2025 | marketbeat.comBright Minds Biosciences (NASDAQ:DRUG) Upgraded to Strong-Buy at Cantor FitzgeraldMay 17, 2025 | marketbeat.comBright Minds Biosciences (DRUG) to Release Earnings on WednesdayMay 16, 2025 | marketbeat.comTD Cowen Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG)May 15, 2025 | marketbeat.comTD Cowen Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy RecommendationMay 14, 2025 | msn.comBright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101May 13, 2025 | finance.yahoo.comChardan Capital Initiates a Buy Rating on Bright Minds Biosciences (DRUG)May 9, 2025 | theglobeandmail.comBright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Rating of "Buy" from BrokeragesMay 9, 2025 | marketbeat.com Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DRUG Media Mentions By Week DRUG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRUG News Sentiment▼0.890.73▲Average Medical News Sentiment DRUG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRUG Articles This Week▼42▲DRUG Articles Average Week Get the Latest News and Ratings for DRUG and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Schrodinger News Today Syndax Pharmaceuticals News Today AbCellera Biologics News Today Amphastar Pharmaceuticals News Today Stoke Therapeutics News Today Tilray Brands News Today Evotec News Today Arcus Biosciences News Today Intellia Therapeutics News Today Tourmaline Bio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRUG) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRUG Stock Alerts